JENNIFER BYER MD NPI 1336438522

NPI Details

Jennifer Byer, MD is a medical oncology internal medicine in Vero Beach, FL with 15 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Jennifer Byer, MD NPI is 1336438522. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Graduation Year:2011

The provider's business location address is:

3730 7TH TER STE 100
VERO BEACH, FL
ZIP 32960-324
Phone: (772) 581-0528
Fax: (772) 581-0535

The NPI 1336438522 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Automated urinalysis test (HCPCS:81003)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Iron level (HCPCS:83540)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Folic acid level, serum (HCPCS:82746)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Red blood count, manual test (HCPCS:85044)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Magnesium level (HCPCS:83735)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Protein measurement, serum (HCPCS:84165)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Red blood count, automated test (HCPCS:85045)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection of drug or substance into vein (HCPCS:96374)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Drawing of blood for a medical problem (HCPCS:99195)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Phosphate level (HCPCS:84100)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Uric acid level, blood (HCPCS:84550)
• Biofeedback training for bowel or bladder control, initial 15 minutes (HCPCS:90912)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Urinalysis, manual test (HCPCS:81002)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Limited ultrasound scan of pelvis (HCPCS:76857)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Testosterone (hormone) level, total (HCPCS:84403)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Vitamin d-3 level (HCPCS:82306)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hemoglobin a1c level (HCPCS:83036)

The enumeration date for this NPI number is 3/29/2011 and was last updated on 4/26/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.